Regulatory T cells in ovarian cancer: biology and therapeutic potential (Q36321305)

13 August 2017

1 reference

title

Regulatory T cells in ovarian cancer: biology and therapeutic potential (English)

1 reference

13 August 2017

1 reference

Ilona Kryczek

1 reference

13 August 2017

Brian Barnett

1 reference

13 August 2017

Pui Cheng

series ordinal

1 reference

13 August 2017

Weiping Zou

series ordinal

1 reference

13 August 2017

Tyler J Curiel

series ordinal

1 reference

13 August 2017

publication date

1 December 2005

1 reference

American Journal of Reproductive Immunology

13 August 2017

published in

1 reference

13 August 2017

1 reference

13 August 2017

1 reference

13 August 2017

page(s)

369-377

1 reference

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00330.X

Immunobiology of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00330.X

Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00330.X

IL-6 switches the differentiation of monocytes from dendritic cells to macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00330.X

Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00330.X

Immunosuppressive networks in the tumour environment and their therapeutic relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00330.X

Future directions in the management of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00330.X

Tumor-specific killer cells in paraneoplastic cerebellar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00330.X

The experimental study of ovarian carcinoma vaccine modified by human B7-1 and IFN-gamma genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00330.X

Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00330.X

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00330.X

Immunologic principles and immunotherapeutic approaches in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00330.X

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00330.X

Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00330.X

Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00330.X

Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00330.X

Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00330.X

A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00330.X

Differentiation of T regulatory cells by immature dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00330.X

Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00330.X

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00330.X

Regulatory T cells in transplantation tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00330.X

Antigen-induced regulatory T cells in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00330.X

CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00330.X

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00330.X

CD4+CD25+ suppressor lymphocytes in the circulation of patients immunized against melanoma antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00330.X

Regulatory T cells under scrutiny

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00330.X

Inhibition of human CD4(+)CD25(+high) regulatory T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00330.X

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00330.X

Cutting edge: depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00330.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00330.X

10.1111/J.1600-0897.2005.00330.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference